-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-drugs-utilization_research.pdf
March 01, 2011 - Utilization of antidiabetic drugs among Medicare
beneficiaries with diabetes, 2006-2009
Diabetes Treatment … Several types of insulin and other injectable drugs such as
amylin analogs and glucagon-like peptide … Drugs Aging 2009;26(Suppl 1):53-62.
3. Abbatecola AM, Maggi S, Paolisso G. … Drugs Aging
2008;25(11):913-25.
4. Feil D, Weinreb J, Sultzer D. … Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/hypertension-drugs-utilization_research.pdf
January 25, 2011 - Further, it
examines costs of antihypertensive drugs. … In 2009, the total drug cost
for antihypertensive drugs was $4.3 bil-
lion. … Identification of Antihypertensive Drugs
and Classes: Oral prescriptions of anti-
hypertensive drugs … Table 2: Antihypertensive drugs examined in this brief
Drug Class Drugs
Angiotensin-converting
enzyme … Use of antihypertensive drugs
by Medicare enrollees: does type of drug coverage matter?
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
January 01, 2011 - Drug Information, DrugPoints, Clinical
Pharmacology, DRUGDEX, National Comprehensive Cancer
Network Drugs
-
effectivehealthcare-admin.ahrq.gov/health-topics/club-drugs
Description
Club drugs are group of psychoactive drugs. … These drugs are often abused by young adults at all-night dance parties, dance clubs, and bars. … Other uses of these drugs are abuse. … Club drugs are also sometimes used as "date rape" drugs, to make someone unable to say no to or fight … Abusing these drugs can cause serious health problems and sometimes death.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
January 01, 2011 - expen-
ditures treated either cancer or potential sequelae of cancer
(e.g., anemia).4 Two of these drugs … Using 2006
data, the Centers for Medicare & Medicaid Services (CMS)
reported on the top 100 Part D drugs … Limits on Medicare’s ability to control rising spending on cancer
drugs. … Top 100 drugs by utilization and class variations
in generic dispensing rates. … Available at: www.aarp.org/health/drugs-
supplements/info-2007/fs136_biologics.html.
-
effectivehealthcare-admin.ahrq.gov/products/high-risk-drugs/protocol
September 01, 2023 - Evidence Reports
Making Healthcare Safer IV: Protocols for High-Risk Drugs … SHARE:
Making Healthcare Safer IV: Protocols for High-Risk Drugs … The “Protocols for High-Risk Drugs: Reducing Adverse Drug Events Related to Anticoagulants” as a patient … High-Alert Drugs: Patient Safety Practices for Intravenous Anticoagulants. … https://effectivehealthcare.ahrq.gov/products/high-risk-drugs/protocol
-
effectivehealthcare-admin.ahrq.gov/products/diabetes-drugs-utilization/research
December 01, 2019 - Home
Evidence Reports
Data Points #9: Utilization of antidiabetic drugs … SHARE:
Data Points #9: Utilization of antidiabetic drugs … Several types of insulin and other injectable drugs such as amylin analogs and glucagon-like peptide- … Project Timeline
Data Points #9: Utilization of antidiabetic drugs among Medicare beneficiaries with … https://effectivehealthcare.ahrq.gov/products/diabetes-drugs-utilization/research
-
effectivehealthcare-admin.ahrq.gov/health-topics/drugs-and-young-people
March 03, 2016 - S
T
U
V
W
X
Y
Z
Health Topics
Drugs … Abused drugs include
Amphetamines
Anabolic steroids
Club drugs
Cocaine
Heroin
Inhalants … Marijuana
Prescription drugs
There are different types of treatment for drug abuse.
-
effectivehealthcare-admin.ahrq.gov/products/cancer-drugs-utilization/research
December 01, 2019 - Drug Information, DrugPoints, Clinical Pharmacology, DRUGDEX, National Comprehensive Cancer Network Drugs … https://effectivehealthcare.ahrq.gov/products/cancer-drugs-utilization/research
-
effectivehealthcare-admin.ahrq.gov/products/hypertension-drugs-utilization/research
December 01, 2019 - Most patients with hypertension will require two or more antihypertensive drugs to control their blood … This Data Points brief explores the prevalence of hypertension and utilization of antihypertensive drugs … Further, it examines costs of antihypertensive drugs. … https://effectivehealthcare.ahrq.gov/products/hypertension-drugs-utilization/research
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s13.pdf
October 01, 2007 - Historically, those who investigate the effects of mar-
keted pharmaceuticals have focused on the risk … Unique Problems in the Study of
Pharmaceuticals
Exposure misclassification is a unique challenge in … Indeed, the confounders of
concern are usually other drugs or other diseases. … In addition, studies of pharmaceuticals, especially stud-
ies of the effectiveness of pharmaceuticals … CONCLUSIONS
The goal of our research community is to optimize the
use of pharmaceuticals by improving
-
effectivehealthcare-admin.ahrq.gov/products/high-risk-drugs/rapid-research
January 01, 2024 - Project Timeline
Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug Events … https://effectivehealthcare.ahrq.gov/products/high-risk-drugs/rapid-research
-
effectivehealthcare-admin.ahrq.gov/products/cancer-drugs-utilization-cost/research
December 01, 2019 - Drugs used in the treatment of cancer account for a large share of Medicare Part B drug expenditures. … Two of these drugs, rituximab and bevacizumab, are biologics. … Using 2006 data, the Centers for Medicare & Medicaid Services (CMS) reported on the top 100 Part D drugs … https://effectivehealthcare.ahrq.gov/products/cancer-drugs-utilization-cost/research
-
effectivehealthcare-admin.ahrq.gov/products/eccs-2006/white-paper
November 01, 2017 - Evidence Reports
Communicating Harms and Benefits of Prescription Drugs … SHARE:
Communicating Harms and Benefits of Prescription Drugs … Communicating Harms and Benefits of Prescription Drugs to Healthcare Consumers (PPT, 153 kb)
What … Evidence" to Healthcare Consumers: Applying Social Marketing to Evidence About the Harms and Benefits of Pharmaceuticals … 1.0 MB)
Project Timeline
Communicating Harms and Benefits of Prescription Drugs
-
effectivehealthcare-admin.ahrq.gov/products/dietary-supplements/research-protocol
December 01, 2019 - dietary supplements (when compared to cardiovascular drugs alone or cardiovascular drugs and a different … Classes of commonly used cardiovascular drugs to be considered (excluding drugs used exclusively for … Analytic Framework for Dietary Supplement Use in Adults Taking Cardiovascular Drugs. … Drugs Aging 2009;26(Suppl 1):41-51.
Garner JB. … Drugs 2009;69:1777-98.
Miller KL, Liebowitz RS, Newby LK.
-
effectivehealthcare-admin.ahrq.gov/products/migraine-prevention/research-protocol
December 01, 2019 - Drugs approved by the FDA for migraine prevention and off-label drugs examined in clinical trials. … Ariston Pharmaceuticals, Inc. … Elan Pharmaceuticals
Eli Lilly and Company
Endo Pharmaceuticals
EUROHEAD
GlaxoSmithKline
HaEmek … King Pharmaceuticals
Lotus Pharmaceutical
MAP Pharmaceuticals, Inc. … Nordlandssykehuset HF
Novartis
NPS Pharmaceuticals
NuPathe Inc.
-
effectivehealthcare-admin.ahrq.gov/health-topics/drug-reactions
November 19, 2012 - One problem is interactions, which may occur between
Two drugs, such as aspirin and blood thinners … Drugs and food, such as statins and grapefruit
Drugs and supplements, such as ginkgo and blood thinners … or both drugs. … The drugs might not work, or you could get side effects. … Side effects are unwanted effects caused by the drugs.
-
effectivehealthcare-admin.ahrq.gov/products/off-label-use-research-priorities/research
June 01, 2020 - years (based from 12/31/06) were coded as 1.0, drugs approved between 4-13 years as 0.5, and drugs approved … drugs are consistent across the lists. … Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals … The Drug Safety index value is coded as 1 for drugs with a black box warning, 0.5 for drugs that had … The Market Entry index value is coded as 1 for drugs that entered within the past 3 years, 0.5 for drugs
-
effectivehealthcare-admin.ahrq.gov/products/migraine-prevention/research-2013
December 01, 2019 - Studies that compared drugs with inactive controls, nonpharmacologic interventions, or other drugs were … For episodic migraine, RCTs examined 59 drugs from 14 drug classes. … All approved drugs (topiramate, divalproex, timolol, and propranolol), some off-label beta blockers, … Drugs would result in clinical improvement in 200 to 400 patients per 1,000 treated. … Evidence on improving quality of life was inconsistent across individual drugs.
-
effectivehealthcare-admin.ahrq.gov/products/grant-manuscripts/rapid-network-abstract
June 01, 2024 - Abstract | October 2019 Objective: To test rapid approaches that use Drugs … @FDA (a public database of approved drugs) and ClinicalTrials.gov to identify trials and to compare these … Study design and setting: We searched bibliographic databases, Drugs@FDA, and ClinicalTrials.gov for … precise effect estimates and similar relative rankings for available interventions using trials from Drugs … Conclusions: A rapid NMA approach using data from Drugs@FDA is feasible but has its own limitations.